Announcements Trials

Browse Landscape

Phase

Phase 1 42 Phase 2 32 Phase 1/2 17 Phase NA 15 Phase 3 5 Phase EARLY_PHASE1 2 Phase 4 1

Status

Completed 2 Unknown 1 Terminated 1 Recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Breast Neoplasms 18 Neoplasms 16 Prostatic Neoplasms 12 Neoplasm Metastasis 10 Pain 9 Colorectal Neoplasms 9 Carcinoma, Non-Small-Cell Lung 9 Lung Neoplasms 8 Polycystic Ovary Syndrome 7 Leiomyoma 6 Anemia 5 Skin Neoplasms 4 Precursor Cell Lymphoblastic Leukemia-Lymphoma 4 Pancreatic Neoplasms 4 Ovarian Neoplasms 4 Leukemia, Myelogenous, Chronic, BCR-ABL Positive 4 Leukemia 4 Carcinoma, Renal Cell 4 Recurrence 3 Melanoma 3 Liver Neoplasms 3 Kidney Neoplasms 3 Keratosis, Actinic 3 Insulin Resistance 3 Carcinoma, Hepatocellular 3 Cancer Pain 3 Brain Neoplasms 3 Uterine Cervical Neoplasms 2 Thyroid Neoplasms 2 Stomach Neoplasms 2

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 4 × Terminated × Burkitt Lymphoma × Clear all

NCT02618109 2022-10-03

LABMI

University Hospital, Angers

Phase 4 Terminated

Burkitt Lymphoma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡